JHVEPhoto
- San Diego, California-based biotech Organovo Holdings (NASDAQ:ONVO) introduced Tuesday that Eli Lilly (NYSE:LLY) has agreed to accumulate its scientific drug growth program concentrating on farnesoid X receptor (“FXR”) agonists.
- Shares of the nano-cap biotech climbed ~203% within the premarket after the
